Enovis Corp

Enovis Corp

ENOV · NYSE · Healthcare / Medical Devices

27.68USD+0.04 (+0.14%)

Price History

Full chart

Market Stats

Previous Close27.64
Open28.65
Day Range27.63 – 28.89
52-Week Range17.30 – 34.28
Volume1.21M
Market Cap1.05B
P/E (TTM)0.00
Forward P/E4.64
EPS-19.27
Dividend Yield0.00%
Beta1.43
50-Day Avg24.09
200-Day Avg24.06

About

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Damien McDonald
  • Employees7.80K
  • Headquarters2900 Lake Vista Drive, Lewisville, TX, United States, 75067, USA
  • Websitehttps://www.enovis.com

Leadership

  • Mr. Damien McDonaldCEO & Director · b. 1965
  • Mr. Phillip Benjamin BerrySenior VP & CFO · b. 1979
  • Ms. Patricia A. LangAdvisor · b. 1959
  • Mr. Terry D. RossGroup President Prevention & Recovery · b. 1970
  • Mr. Louie VogtGroup President of Reconstructive · b. 1981
  • Mr. John KlecknerVP, Controller & Chief Accounting Officer · b. 1977
  • Mr. Oliver EngertChief Administrative Officer · b. 1965
  • Mr. Kyle William RoseVice President of Investor Relations
  • Mr. Bradley J. Tandy J.D.Senior VP & Chief Legal Officer · b. 1959
  • Ms. Laura SingletonSenior VP & Chief Human Resources Officer

Financials

Income Statement

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue309.65M345.48M393.60M506.31M604.85M525.02M541.99M693.39M3.91B4.21B4.62B3.97B3.65B3.30B2.19B3.33B3.07B1.43B1.56B1.71B2.11B2.25B
Growth (%)-+11.57%+13.93%+28.63%+19.46%-13.20%+3.23%+27.94%+464.45%+7.50%+9.92%-14.22%-8.07%-9.51%-33.55%+51.73%-7.71%-53.56%+9.60%+9.22%+23.46%+6.66%
Cost of Revenue197.91M222.35M256.81M330.71M387.67M339.24M350.58M453.29M2.76B2.90B3.15B2.72B2.50B2.27B1.46B1.93B1.78B648.51M693.72M716.42M926.87M902.79M
Gross Profit111.75M123.13M136.80M175.59M217.19M185.79M191.41M240.10M1.15B1.31B1.48B1.25B1.15B1.03B729.38M1.40B1.29B777.67M869.38M990.78M1.18B1.35B
Gross Margin36.09%35.64%34.76%34.68%35.91%35.39%35.32%34.63%29.44%31.05%31.98%31.55%31.41%31.19%33.26%42.11%41.95%54.53%55.62%58.04%56.02%59.84%
Operating Expense110.02M95.56M117.25M52.32M200.50M147.33M157.04M214.19M1.01B899.83M1.07B967.13M907.64M1.00B577.84M1.20B1.13B840.47M940.56M1.06B1.96B1.36B
Operating Income1.73M27.56M19.54M123.28M16.69M38.46M34.37M25.91M140.01M406.39M409.55M284.64M238.01M29.15M151.54M203.61M162.29M-62.80M-71.18M-65.71M-775.72M-18.87M
Operating Margin0.56%7.98%4.97%24.35%2.76%7.33%6.34%3.74%3.58%9.66%8.86%7.18%6.53%0.88%6.91%6.12%5.29%-4.40%-4.55%-3.85%-36.81%-0.84%
EBITDA1.73M38.99M32.68M140.16M16.69M54.70M34.37M25.91M140.01M525.65M409.55M430.59M349.26M160.41M330.29M406.02M180.05M170.25M241.69M169.73M-481.03M-830.22M
EBITDA Margin0.56%11.29%8.30%27.68%2.76%10.42%6.34%3.74%3.58%12.49%8.86%10.85%9.58%4.86%15.06%12.20%5.86%11.94%15.46%9.94%-22.82%-36.93%
Net Income57.31M12.25M94.00K64.88M-571.00K21.72M16.21M4.55M-64.40M178.63M392.10M167.74M128.11M151.09M140.20M-527.65M42.63M71.66M-13.29M-33.26M-825.49M-1.18B
Net Income Margin18.51%3.54%0.02%12.81%-0.09%4.14%2.99%0.66%-1.65%4.25%8.48%4.23%3.51%4.58%6.39%-15.86%1.39%5.02%-0.85%-1.95%-39.17%-52.69%
R&D3.17M2.85M3.34M4.16M5.86M5.93M6.21M5.71M19.40M27.40M43.00M41.50M39.30M42.90M34.20M61.80M34.27M49.09M60.83M75.33M91.30M120.33M
R&D as % of Total Revenue1.03%0.83%0.85%0.82%0.97%1.13%1.14%0.82%0.50%0.65%0.93%1.05%1.08%1.30%1.56%1.86%1.12%3.44%3.89%4.41%4.33%5.35%
Interest Expense6.92M---11.82M7.21M6.68M5.92M91.57M103.60M51.30M47.74M30.02M40.11M49.08M119.50M52.82M29.11M24.95M19.75M57.10M34.82M
Interest Expense % of Total Revenue2.23%---1.95%1.37%1.23%0.85%2.34%2.46%1.11%1.20%0.82%1.22%2.24%3.59%1.72%2.04%1.60%1.16%2.71%1.55%

Balance Sheet

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets707.88M700.57M797.23M896.54M913.08M1.00B1.02B1.09B6.13B6.58B7.25B6.73B6.39B6.72B6.60B7.39B7.35B8.52B4.27B4.51B4.72B3.83B
Total Liabilities609.79M708.15M791.33M843.49M746.14M804.30M805.71M899.27M3.97B3.84B3.89B3.48B3.29B2.99B3.13B3.90B3.76B3.85B823.45M1.09B2.15B2.34B
Total Equity98.09M-7.58M5.90M53.05M166.93M198.83M216.37M189.28M1.91B2.51B3.15B3.07B2.90B3.50B3.27B3.44B3.54B4.62B3.45B3.42B2.56B1.49B
Cash-7.82M7.61M48.09M28.76M49.96M60.54M75.11M482.45M311.30M305.45M197.47M221.73M262.02M245.02M109.63M101.07M680.25M24.30M36.19M48.17M36.39M
Total Debt-158.45M188.72M206.49M97.12M91.48M82.50M111.52M1.73B1.49B1.54B1.42B1.29B1.06B1.20B2.49B2.41B2.16B334.82M536.42M1.40B1.38B
Net Debt-150.63M181.11M158.40M68.36M91.48M82.50M111.52M1.25B1.18B1.23B1.22B1.08B799.05M1.12B2.38B2.31B1.48B310.52M500.23M1.36B1.34B

Cash Flow

Currency: USD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.75M-17.36M74.48M-31.51M38.29M61.97M57.15M164.30M362.17M385.76M303.81M246.97M218.77M226.37M130.95M301.94M356.10M-55.86M134.99M113.50M217.29M
Investing Cash Flow-18.43M-10.08M-46.52M-20.53M-12.05M-40.41M-69.97M-1.94B-474.97M-1.03B-246.96M-81.99M89.88M-167.85M-1.63B-175.08M-320.48M-176.39M-242.47M-955.47M-179.37M
Financing Cash Flow-65.90M26.56M11.74M34.84M-5.42M-8.04M32.74M2.19B-45.05M650.05M-131.27M-145.22M-280.45M-47.15M1.37B-131.65M584.91M-465.13M127.80M846.82M-52.40M
Capital Expenditure7.08M10.24M13.67M20.11M11.01M12.53M14.79M83.59M71.48M81.34M69.88M63.25M68.77M69.65M125.40M114.78M104.24M105.45M122.22M180.71M197.38M
Free Cash Flow-14.84M-27.59M60.81M-51.63M27.28M49.44M42.37M80.71M290.69M304.42M233.94M183.72M150.00M156.72M5.55M187.15M251.86M-161.31M12.77M-67.21M19.92M
Dividends Paid18.74M--38.55M38.55B--17.45M20.40M3.85M2.25B896.74M-1.27B-------
FCF to OCF191.32%158.98%81.65%163.82%71.25%79.78%74.13%49.13%80.26%78.91%77.00%74.39%68.57%69.23%4.24%61.98%70.73%288.77%9.46%-59.21%9.17%
Dividend Paid to FCF-126.34%---74.66%141297.65%--21.61%7.02%1.27%960.96%488.09%-811.03%-------

Earnings

Report DateJun 17, 2008Aug 5, 2008Nov 5, 2008Feb 20, 2009May 8, 2009Aug 4, 2009Nov 3, 2009Feb 18, 2010Apr 30, 2010Jul 28, 2010Nov 4, 2010Feb 15, 2011May 3, 2011Jul 29, 2011Oct 27, 2011Feb 7, 2012May 8, 2012Jul 27, 2012Oct 25, 2012Feb 6, 2013Apr 25, 2013Jul 25, 2013Oct 24, 2013Feb 6, 2014Apr 24, 2014Jul 17, 2014Oct 23, 2014Feb 5, 2015Apr 23, 2015Jul 23, 2015Oct 14, 2015Feb 4, 2016May 3, 2016Jul 28, 2016Oct 27, 2016Feb 2, 2017May 5, 2017Jul 28, 2017Nov 6, 2017Feb 6, 2018May 3, 2018Aug 6, 2018Oct 25, 2018Feb 13, 2019May 8, 2019Aug 6, 2019Oct 31, 2019Feb 21, 2020May 7, 2020Aug 6, 2020Oct 29, 2020Feb 18, 2021Apr 29, 2021Jul 28, 2021Nov 4, 2021Feb 22, 2022May 10, 2022Aug 4, 2022Nov 2, 2022Feb 23, 2023May 4, 2023Aug 3, 2023Nov 7, 2023Feb 22, 2024May 2, 2024Aug 7, 2024Nov 6, 2024Feb 20, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-0.880.850.970.710.750.590.710.290.470.580.980.600.770.901.360.631.100.941.180.721.581.591.761.311.971.831.901.001.421.221.290.811.161.041.320.891.291.231.291.281.561.581.901.481.841.421.671.120.181.171.491.191.611.611.740.350.500.480.660.380.520.540.740.480.590.610.920.740.740.650.810.810.790.64
EPS Actual0.930.960.841.200.720.600.690.780.390.540.661.170.690.961.111.200.691.050.991.260.781.681.681.831.291.441.712.161.081.500.721.530.901.231.171.381.051.291.261.351.441.831.622.071.591.621.501.831.140.271.231.531.321.681.621.770.370.590.590.720.440.610.560.790.500.620.730.980.810.790.750.950.890.76-
Surprise-9.09%-1.18%23.71%1.41%-20.00%16.95%9.86%34.48%14.89%13.79%19.39%15.00%24.68%23.33%-11.76%9.52%-4.55%5.32%6.78%8.33%6.33%5.66%3.98%-1.53%-26.90%-6.56%13.68%8.00%5.63%-40.98%18.60%11.11%6.03%12.50%4.55%17.98%0.00%2.44%4.65%12.50%17.31%2.53%8.95%7.43%-11.96%5.63%9.58%1.79%50.00%5.13%2.68%10.92%4.35%0.62%1.72%5.71%18.00%22.92%9.09%15.79%17.31%3.70%6.76%4.17%5.08%19.67%7.02%9.46%6.76%15.38%17.28%9.88%-3.80%-
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap1.05B
Enterprise Value2.41B
Trailing P/E0.00
Forward P/E4.64
PEG Ratio1.90
Price / Sales0.46
Price / Book0.71
EPS-19.27
Book Value25.62
Revenue (TTM)2.30B
Gross Profit (TTM)1.41B
EBITDA379.78M
Profit Margin-47.97%
Operating Margin4.19%
Return on Equity-54.14%
Return on Assets1.20%
Shares Outstanding57.67M
Shares Float52.76M
Beta1.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 11 analystsTarget 38.33
  • Strong Buy
    7
  • Buy
    3
  • Hold
    1

Ownership Breakdown

Institutions
125.12%
Insiders
1.64%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    9.94M17.23%
  • American Century Companies Inc
    6.11M10.59%
  • Vanguard Portfolio Management, LLC
    3.81M6.60%
  • Vanguard Capital Management, LLC
    2.55M4.43%
  • Rubric Capital Management LP
    2.45M4.25%
  • State Street Corp
    2.40M4.17%
  • Davenport & Company LLC
    2.34M4.06%
  • Hood River Capital Management LLC
    1.76M3.05%
  • Dimensional Fund Advisors, Inc.
    1.74M3.03%
  • The Goldman Sachs Group Inc
    1.57M2.72%
  • Paradigm Capital Management, Inc.
    1.38M2.39%
  • Geode Capital Management, LLC
    1.37M2.38%
  • FMR Inc
    1.36M2.36%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    3.51M6.08%
  • American Century Small Cap Value Inv
    2.69M4.66%
  • Avantis US Small Cap Value ETF
    1.84M3.19%
  • Fidelity Small Cap Value Fund
    1.84M3.19%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.74M3.02%
  • iShares Russell 2000 ETF
    1.49M2.58%
  • Vanguard Small Cap Index
    1.26M2.18%

Stock Splits

  • Apr 5, 2022581:1000